Scarica l'app Stockscreener
15.85
1.64%
-0.265
Precedente Chiudi:
$16.11
Aprire:
$15.84
Volume 24 ore:
544.65K
Relative Volume:
0.67
Capitalizzazione di mercato:
$1.18B
Reddito:
$97.36M
Utile/perdita netta:
$-172.42M
Rapporto P/E:
-6.8961
EPS:
-2.2984
Flusso di cassa netto:
$-188.84M
1 W Prestazione:
+5.67%
1M Prestazione:
+33.98%
6M Prestazione:
+14.11%
1 anno Prestazione:
+70.80%
Intervallo 1D:
$15.11
$15.89
Intervallo di 1 settimana:
$14.61
$16.98
Portata 52W:
$6.92
$18.69
Xencor Inc Stock (XNCR) Company Profile
Nome
Xencor Inc
Settore
Industria
Telefono
626-305-5900
Indirizzo
465 N. HALSTEAD ST., PASADENA, CA
Compare XNCR vs VRTX, REGN, ARGX, ALNY, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
XNCR
Xencor Inc
|
15.85 | 1.18B | 97.36M | -172.42M | -188.84M | -2.2984 |
VRTX
Vertex Pharmaceuticals Inc
|
485.39 | 123.19B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
664.52 | 69.67B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
877.62 | 54.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
298.76 | 39.89B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
186.88 | 39.73B | 742.00K | -1.37B | -1.07B | -7.0731 |
Xencor Inc Stock (XNCR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-03-24 | Downgrade | JP Morgan | Overweight → Neutral |
| 2025-11-24 | Iniziato | Truist | Buy |
| 2025-10-29 | Aggiornamento | Barclays | Underweight → Overweight |
| 2025-09-17 | Ripresa | Barclays | Underweight |
| 2025-09-03 | Downgrade | BofA Securities | Buy → Neutral |
| 2025-04-21 | Iniziato | William Blair | Outperform |
| 2024-12-12 | Iniziato | Wells Fargo | Overweight |
| 2024-12-02 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2024-04-16 | Reiterato | BTIG Research | Buy |
| 2024-02-28 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2023-05-19 | Iniziato | BofA Securities | Buy |
| 2022-12-06 | Iniziato | Cowen | Outperform |
| 2022-10-13 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2022-09-21 | Iniziato | JP Morgan | Overweight |
| 2022-07-06 | Ripresa | Canaccord Genuity | Buy |
| 2022-02-11 | Iniziato | BMO Capital Markets | Outperform |
| 2022-01-21 | Iniziato | SMBC Nikko | Outperform |
| 2021-12-15 | Iniziato | H.C. Wainwright | Buy |
| 2021-10-15 | Ripresa | BTIG Research | Buy |
| 2021-02-24 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2020-03-04 | Iniziato | Barclays | Underweight |
| 2020-02-25 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2020-01-30 | Iniziato | RBC Capital Mkts | Outperform |
| 2019-11-20 | Ripresa | Guggenheim | Neutral |
| 2019-08-07 | Downgrade | Guggenheim | Buy → Neutral |
| 2019-08-07 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2019-06-13 | Iniziato | Mizuho | Buy |
| 2019-04-12 | Iniziato | Guggenheim | Buy |
| 2019-03-27 | Iniziato | Berenberg | Buy |
| 2019-03-15 | Iniziato | Raymond James | Outperform |
| 2018-09-10 | Ripresa | BTIG Research | Buy |
| 2018-03-28 | Ripresa | Leerink Partners | Outperform |
| 2017-03-02 | Iniziato | Instinet | Neutral |
| 2017-03-02 | Reiterato | Wedbush | Outperform |
| 2016-10-04 | Iniziato | Piper Jaffray | Overweight |
| 2015-12-22 | Iniziato | Canaccord Genuity | Buy |
| 2015-08-05 | Reiterato | MLV & Co | Buy |
| 2015-02-12 | Reiterato | Oppenheimer | Outperform |
| 2015-01-28 | Reiterato | MLV & Co | Buy |
| 2014-07-11 | Iniziato | Oppenheimer | Outperform |
Mostra tutto
Xencor Inc Borsa (XNCR) Ultime notizie
(XNCR) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Form 4 Xencor Inc For: 8 July By Investing.com - Investing.com Nigeria
Ellen Feigal at Xencor (XNCR) receives RSUs and options equity awards - Stock Titan
Xencor (XNCR) awards RSUs and stock options to director Gorman - Stock Titan
Xencor (XNCR) director Kurt Gustafson granted RSUs and stock options - Stock Titan
[Form 4] Xencor Inc Insider Trading Activity - Stock Titan
Xencor (XNCR) director granted RSUs and stock options in equity award - Stock Titan
Xencor (XNCR) director granted RSUs and 20,604 stock options at $12.20 - Stock Titan
Xencor (NASDAQ: XNCR) director receives new RSU and stock option grant - Stock Titan
Truist Financial Maintains Xencor(XNCR.US) With Buy Rating, Cuts Target Price to $27 - Moomoo
XENCOR Maintains Buy Rating -- Price Target Lowered to $27.00 by Truist Securities - GuruFocus
XNCRXencor Inc Revenue Breakdown - Finviz
Enterprise value to revenue forward of Xencor, Inc. – NASDAQ:XNCR - TradingView
Price to earnings forward of Xencor, Inc. – NASDAQ:XNCR - TradingView
Price to sales forward of Xencor, Inc. – NASDAQ:XNCR - TradingView
Price to sales forward of Xencor, Inc. – TRADEGATE:XE9 - TradingView
Liquidity Mapping Around (XNCR) Price Events - Stock Traders Daily
XE9 Forecast — Price Target — Prediction for 2027 - TradingView
Xencor, Inc. Actuals & Estimates (FWB:XE9) - TradingView
XNCR Forecast — Price Target — Prediction for 2027 - TradingView
Xencor, Inc. Actuals & Estimates (NASDAQ:XNCR) - TradingView
Price to book forward of Xencor, Inc. – NASDAQ:XNCR - TradingView
Xencor Inc (XNCR) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Xencor director Ellen Feigal sells $89,369 in company stock By Investing.com - Investing.com South Africa
Insider Sell Alert: Ellen Feigal Sells Shares of Xencor Inc (XNC - GuruFocus
Form 4 Xencor Inc For: 22 June By Investing.com - Investing.com Nigeria
Xencor director Ellen Feigal sells $89,369 in company stock - Investing.com
Xencor (XNCR) director’s 10b5-1 sale covers 6,843 common shares - Stock Titan
XNCR Q1 2026 Earnings: Deep Loss Miss Weighs on SentimentProfit Warning Alert - dars.gov.et
Xencor, Inc. Files 8-K: Company Details, Stock Info, and Executive Plan Updates for 2026 - Minichart
Xencor Shareholders Approve Directors, Incentive Plan Amendments - TipRanks
Why (XNCR) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Xencor (NASDAQ: XNCR) investors back 4M-share equity plan boost and all proposals - Stock Titan
Xencor Inc (XNCR) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
[144] Xencor Inc SEC Filing - Stock Titan
Insider Sell Alert: Richard Ranieri Sells Shares of Xencor Inc (XNCR) - GuruFocus
Xencor Inc (XNCR) Valuation: PE, PB & Fair Value Analysis - TradingKey
Xencor Inc (XNCR) Institutional Confidence - TradingKey
Xencor Inc (XNCR) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Xencor Inc (XNCR) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Xencor Inc (XNCR) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Xencor Inc (XNCR) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Xencor Inc (XNCR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Director at Xencor (XNCR) sells 7,527 shares under 10b5-1 plan - Stock Titan
Xencor (XNCR) director sells 5,474 shares under Rule 10b5-1 plan - Stock Titan
Xencor (XNCR) director Ranieri sells 5,474 shares under 10b5-1 plan - Stock Titan
Planned share sale by Xencor (XNCR) director under Rule 10b5-1 plan - Stock Titan
Barclays Maintains Xencor(XNCR.US) With Buy Rating, Maintains Target Price $27 - Moomoo
Xencor (XNCR) Stock Draws Fresh Price Target Split As Pipeline Progress Meets Caution - Yahoo Finance
Xencor Inc Stock (US98401F1057): Analyst Views In Focus After Recent Collaboration Momentum - AD HOC NEWS
Understanding Momentum Shifts in (XNCR) - Stock Traders Daily
Xencor Inc Azioni (XNCR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.64%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):